Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission

Mapping Intimacies ◽

10.1002/14651858.cd010248 ◽

2012 ◽

Author(s):

Chen Mao ◽

Ya-Fang Huang ◽

Zu-Yao Yang ◽

Qian-Ling YE ◽

Xin-Yin Wu ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Maintenance Therapy ◽

Myeloid Leukaemia ◽

Interleukin 2 ◽

First Complete Remission ◽

Download Full-text

Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd010248.pub2 ◽

2015 ◽

Author(s):

Chen Mao ◽

Xiao-Hong Fu ◽

Jin-Qiu Yuan ◽

Zu-Yao Yang ◽

Ya-Fang Huang ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Maintenance Therapy ◽

Myeloid Leukaemia ◽

Interleukin 2 ◽

First Complete Remission ◽

Download Full-text

Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: A pilot study

Leukemia Research ◽

10.1016/0145-2126(90)90109-m ◽

1990 ◽

Vol 14 (11-12) ◽

pp. 967-973 ◽

Author(s):

Donald Macdonald ◽

Yinzheng Jiang ◽

Andrea A. Gordon ◽

Premini Mahendra ◽

Ralph Oskam ◽

...

Keyword(s):

Pilot Study ◽

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Interleukin 2 ◽

Recombinant Interleukin 2 ◽

First Complete Remission ◽

Download Full-text

Faculty Opinions recommendation of Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958906.793462914 ◽

2012 ◽

Author(s):

Nelson Chao

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Phase 3 ◽

First Complete Remission ◽

Reduced Intensity ◽

Download Full-text

Sustained complete remission of recurrent acute myeloid leukaemia with a single dose of gemtuzumab ozogamicin and low-dose interleukin-2 maintenance

Leukemia ◽

10.1038/sj.leu.2402594 ◽

2002 ◽

Vol 16 (9) ◽

pp. 1870-1871

Author(s):

MP Radsak ◽

HR Salih ◽

M Sökler ◽

L Kanz ◽

C Denzlinger

Keyword(s):

Single Dose ◽

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Low Dose ◽

Interleukin 2 ◽

Gemtuzumab Ozogamicin ◽

Download Full-text

Faculty Opinions recommendation of Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726774118.793548561 ◽

2018 ◽

Author(s):

Stephen Nimer

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Cell ◽

First Complete Remission ◽

Download Full-text

‘Rainy day’ stem cell storage for adult patients with acute myeloid leukaemia in first complete remission

Internal Medicine Journal ◽

10.1111/j.1445-5994.2008.01743.x ◽

2008 ◽

Vol 38 (8) ◽

pp. 680-681

Keyword(s):

Stem Cell ◽

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Adult Patients ◽

Cell Storage ◽

First Complete Remission ◽

Download Full-text

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(12)70349-2 ◽

2012 ◽

Vol 13 (10) ◽

pp. 1035-1044 ◽

Author(s):

Martin Bornhäuser ◽

Joachim Kienast ◽

Rudolf Trenschel ◽

Andreas Burchert ◽

Ute Hegenbart ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Phase 3 ◽

First Complete Remission ◽

Reduced Intensity ◽

Download Full-text

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

British Journal of Haematology ◽

10.1046/j.1365-2141.2003.04057.x ◽

2003 ◽

Vol 120 (2) ◽

pp. 281-288 ◽

Author(s):

Lyle C. Feinstein ◽

Brenda M. Sandmaier ◽

Ute Hegenbart ◽

Peter A. McSweeney ◽

David G. Maloney ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Human Leucocyte Antigen ◽

First Complete Remission ◽

Download Full-text

Histamine dihydrochloride* plus interleukin-2 is beneficial in patients with acute myeloid leukaemia who are in complete remission,

Inpharma Weekly ◽

10.2165/00128413-200414380-00020 ◽

2004 ◽

Vol &NA; (1438) ◽

pp. 9

Author(s):

&NA;

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Interleukin 2 ◽

Histamine Dihydrochloride ◽

Download Full-text

Faculty Opinions recommendation of Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958906.793464270 ◽

2012 ◽

Author(s):

Anskar YH Leung

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Phase 3 ◽

First Complete Remission ◽

Reduced Intensity ◽

Download Full-text